CD274 and non-small cell lung carcinoma: In the context of NSCLC, H3K18la has been implicated in the activation of POM121 transcription, which in turn enhances the nuclear translocation of MYC and directly binds to the CD274 promoter, ultimately up-regulating PD-L1 expression and potentiating immune evasion (135).